about
Salmonella typhimurium translocates flagellin across intestinal epithelia, inducing a proinflammatory responseImmunization of mice with formalin-inactivated spores from avirulent Bacillus cereus strains provides significant protection from challenge with Bacillus anthracis AmesVirulence of the Shiga toxin type 2-expressing Escherichia coli O104:H4 German outbreak isolate in two animal models.Antimicrobial effects of interferon-inducible CXC chemokines against Bacillus anthracis spores and bacilli.Detection of epithelial-cell injury, and quantification of infection, in the HCT-8 organoid model of cryptosporidiosisFerrets as a model system for renal disease secondary to intestinal infection with Escherichia coli O157:H7 and other Shiga toxin-producing E. coli.Antibodies to intimin and Escherichia coli secreted proteins A and B in patients with enterohemorrhagic Escherichia coli infections.Mutations in hns reduce the adherence of Shiga toxin-producing E. coli 091:H21 strain B2F1 to human colonic epithelial cells and increase the production of hemolysin.A plant-based oral vaccine to protect against systemic intoxication by Shiga toxin type 2.Mouse model of hemolytic-uremic syndrome caused by endotoxin-free Shiga toxin 2 (Stx2) and protection from lethal outcome by anti-Stx2 antibody.A novel murine infection model for Shiga toxin-producing Escherichia coli.Overview and Historical Perspectives.New Therapeutic Developments against Shiga Toxin-Producing Escherichia coli.Mapping of genetic loci that modulate differential colonization by Escherichia coli O157:H7 TUV86-2 in advanced recombinant inbred BXD miceEscherichia coli O157:H7 infection in Dutch belted and New Zealand white rabbits.Pathogenesis of Escherichia coli O157:H7 strain 86-24 following oral infection of BALB/c mice with an intact commensal flora.When a healthy diet turns deadlyAntibody against the carboxyl terminus of intimin alpha reduces enteropathogenic Escherichia coli adherence to tissue culture cells and subsequent induction of actin polymerization.Phase 1 safety and pharmacokinetic study of chimeric murine-human monoclonal antibody c alpha Stx2 administered intravenously to healthy adult volunteers.Neutralizing antibodies to Shiga toxin type 2 (Stx2) reduce colonization of mice by Stx2-expressing Escherichia coli O157:H7.Cytotoxic necrotizing factor type 1 production by uropathogenic Escherichia coli modulates polymorphonuclear leukocyte function.Vaccination of pregnant dams with intimin(O157) protects suckling piglets from Escherichia coli O157:H7 infection.One of two copies of the gene for the activatable shiga toxin type 2d in Escherichia coli O91:H21 strain B2F1 is associated with an inducible bacteriophageShiga-like toxin-converting phages from Escherichia coli strains that cause hemorrhagic colitis or infantile diarrhea.Human intestinal tissue and cultured colonic cells contain globotriaosylceramide synthase mRNA and the alternate Shiga toxin receptor globotetraosylceramide.Novel three-dimensional organoid model for evaluation of the interaction of uropathogenic Escherichia coli with terminally differentiated human urothelial cells.Mouse models of Escherichia coli O157:H7 infection and shiga toxin injectionShiga toxin of enterohemorrhagic Escherichia coli type O157:H7 promotes intestinal colonization.Dementia caregiver intervention research: in search of clinical significanceCytotoxic necrotizing factor type 1 delivered by outer membrane vesicles of uropathogenic Escherichia coli attenuates polymorphonuclear leukocyte antimicrobial activity and chemotaxis.Comparisons of native Shiga toxins (Stxs) type 1 and 2 with chimeric toxins indicate that the source of the binding subunit dictates degree of toxicity.Bacillus cereus G9241 makes anthrax toxin and capsule like highly virulent B. anthracis Ames but behaves like attenuated toxigenic nonencapsulated B. anthracis Sterne in rabbits and mice.Antibodies against hemolysin and cytotoxic necrotizing factor type 1 (CNF1) reduce bladder inflammation in a mouse model of urinary tract infection with toxigenic uropathogenic Escherichia coli.Shiga toxin-producing Escherichia coli in Montana: bacterial genotypes and clinical profiles.Reduced Toxicity of Shiga Toxin (Stx) Type 2c in Mice Compared to Stx2d Is Associated with Instability of Stx2c Holotoxin.Multicenter evaluation of a sequence-based protocol for subtyping Shiga toxins and standardizing Stx nomenclatureBacillus anthracis exosporium protein BclA affects spore germination, interaction with extracellular matrix proteins, and hydrophobicityTwo domains of cytotoxic necrotizing factor type 1 bind the cellular receptor, laminin receptor precursor protein.Recombinant exosporium protein BclA of Bacillus anthracis is effective as a booster for mice primed with suboptimal amounts of protective antigen.Adherence and colonization mechanisms of enteropathogenic and enterohemorrhagic Escherichia coli.
P50
Q28345391-33A9ED96-7054-43EA-94BA-96692B4DFB56Q28392659-1B69A710-5EE0-453E-AE2E-E68D2BF9ED70Q30416578-6AFBA145-C8B0-4F3E-A52F-CD8BD4E32959Q30438323-671EDF06-FAF3-46FF-9582-1AD275B86370Q30439316-892927DD-CF43-44A1-A2A7-E0DDA3AD694DQ33341232-DC59D34A-C0A5-4BAE-82EE-58BF0A1948F9Q33341978-6A50E82C-615D-4E1C-BE00-A79B038A3AE9Q33346902-81F274A6-05AB-4192-ADC8-873FACC05169Q33370998-1E72E682-AD65-482E-B4D6-0F796F2F89C8Q33380705-84AC2B6B-5C72-4067-BCB9-05A3879D44E7Q33403695-59E8E546-AB8D-4B7E-8557-11FF2E711CDEQ33419782-09DF95D6-8535-4565-B3F5-E6505C7DE385Q33423832-5B088C74-4A62-4A05-8FEB-C055164E45E4Q33427581-EBED5853-F1C1-40AE-8767-F8CA1598A559Q33676680-FAEDB5C1-06A0-4930-9950-DA7D150AE82AQ33712512-82D3D9DD-428D-4F3B-B826-673AFE323114Q33728306-300B5A76-D97E-4C16-A16A-A1586E64EFFFQ33769414-61192AD1-428E-4E69-9A7D-FE5C6CEF1078Q33770199-F381C546-9B71-4B50-AB9D-CE2352746B1CQ33965188-62BC783F-3BB3-4EC9-8AC7-7068939AF24FQ34034054-575C6A4C-8858-49BE-A4B9-75508D7702FAQ34121794-76836009-AF0E-496A-A84F-01C8DE5E4D66Q34128036-663B2382-B999-40E0-9973-78A1DA4E17CEQ34258393-B3E2493F-9DDC-4561-83CF-C0C337068BFFQ34290908-440774E0-74F4-41A1-9F84-9827F43B4981Q34300908-D94F29C2-34A2-44A0-9ECB-899A8ECD43D6Q34497115-9CD396C3-A8CC-4038-8058-B414B5C271B8Q34667008-3EEC74D2-4055-4C53-958A-836D7C94F5BCQ34915469-4903E1C8-B3AC-46F5-82C0-D29601C612E9Q34975753-5787640E-5DAF-4841-8DFF-D5924FA18C2AQ35132357-08ED4827-B927-4F40-BD74-A487E3561A35Q35139395-8160DEFF-CAE2-4058-90F8-DDA8058AF286Q35187543-10A459FE-FF40-44DF-BF64-76A248D0BE4EQ35204892-2455F2BA-F8E5-46AC-829D-A75DA13B4F3BQ35673972-4BEC4D25-DA4B-459A-964B-03B8EF7F2704Q36172302-EDFCFCDA-BB3A-493C-AD2A-F25C945F8FAEQ36313806-6A8A9872-54F0-4B50-A5FD-E8A648F7557AQ36313840-F3EEC128-6598-4284-A3CB-215507764094Q36313906-9EF0F4EE-5BCA-4948-96A2-51364A356730Q36319476-2FF4E47B-21CC-4FF3-90E0-B0D3090848F6
P50
description
hulumtuese
@sq
researcher
@en
ricercatrice
@it
wetenschapper
@nl
հետազոտող
@hy
name
Alison O'Brien
@ast
Alison O'Brien
@en
Alison O'Brien
@es
Alison O'Brien
@nl
type
label
Alison O'Brien
@ast
Alison O'Brien
@en
Alison O'Brien
@es
Alison O'Brien
@nl
prefLabel
Alison O'Brien
@ast
Alison O'Brien
@en
Alison O'Brien
@es
Alison O'Brien
@nl
P214
P244
P106
P21
P214
P244
P31
P496
0000-0002-1315-3204
P569
2000-01-01T00:00:00Z
P734
P735
P7859
lccn-n98005993